Content Hub

Interview with XNK Therapeutics:

Screenshot 2023-10-09 171331

Ahead of the 2nd Innate Killer Europe Summit next week, we caught up with the CSO of XNK Therapeutics, Anna-Karin Maltais (formerly Roos). In an exclusive interview, she shared some of the most exciting research and breakthroughs in Autologous NK Cell therapies, XNK Therapeutic priorities and focuses, and why she is excited to join the Summit next week!